Business News
IASO Bio Publicizes NMPA’s IND Acclaim for Equecabtagene Autoleucel in Second-Line Therapy of Just a few Myeloma, Industry Info
IASO Bio, a leading biopharmaceutical company specializing in innovative cell therapies and antibody pro...
News and insights